Overexpression of adiponectin improves neurobehavioral outcomes after focal cerebral ischemia in aged mice

CNS Neuroscience and Therapeutics

Volumn 19, Issue 12, 2013, Pages 969-977

  Miao, Jie ^a   Shen, Lin Hui ^a   Tang, Yao Hui ^b   Wang, Yong Ting ^b   Tao, Mei Xin ^b   Jin, Kun Lin ^c   Zhao, Yong Ju ^a   Yang, Guo Yuan ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Adiponectin; Aged mice; Angiogenesis; Cerebral ischemia; Neurobehavioral recovery

Indexed keywords

ADIPONECTIN; PARVOVIRUS VECTOR;

ADENO ASSOCIATED VIRUS; AGED; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ATTENUATION; BRAIN ATROPHY; BRAIN ISCHEMIA; BRAIN SIZE; COGNITION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE OVEREXPRESSION; GENE TRANSFER; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; VIRAL GENE THERAPY; WESTERN BLOTTING;

ADIPONECTIN; AGED MICE; ANGIOGENESIS; CEREBRAL ISCHEMIA; NEUROBEHAVIORAL RECOVERY;

ADENOVIRIDAE; ADIPONECTIN; AGE FACTORS; AGING; ANIMALS; ANTIGENS, CD31; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; MALE; MENTAL DISORDERS; MICE; MICROVESSELS; PHOSPHOPYRUVATE HYDRATASE; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 84888203203     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12198     Document Type: Article

References (54)

1. Wang YJ, Zhang SM, Zhang L, et al. Chinese guidelines for the secondary prevention of ischemic stroke and transient ischemic attack 2010. CNS Neurosci Ther 2012;18:93-101.
2. Fisher M. New approaches to neuroprotective drug development. Stroke 2011;42:S24-S27.
3. Mathai S, Gunn AJ, Backhaus RA, Guan J. Window of opportunity for neuroprotection with an antioxidant, allene oxide synthase, after hypoxia-ischemia in adult male rats. CNS Neurosci Ther 2012;18:887-894.
4. Sena E, van der Worp HB, Howells D, Macleod M. How can we improve the pre-clinical development of drugs for stroke? Trends Neurosci 2007;30:433-439.
5. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW. 1, 026 experimental treatments in acute stroke. Ann Neurol 2006;59:467-477.
6. Deng YX, Wang YL, Gao BQ, et al. Age differences in clinical characteristics, health care, and outcomes after ischemic stroke in China. CNS Neurosci Ther 2012;18:819-826.
7. Kang DH, Anderson S, Kim YG, Mazzalli M. Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis 2001;37:601-611.
8. Gao P, Shen F, Gabriel RA, et al. Attenuation of brain response to vascular endothelial growth factor-mediated angiogenesis and neurogenesis in aged mice. Stroke 2009;40:3596-3600.
9. Di Cesare F, D'Ilario D, Fioravanti M. Differential characteristics of the aging process and the vascular cognitive impairment in the organization of memory retrieval. J Neurol Sci 2012;322:148-151.
10. Bao L, Taskin E, Foster M, et al. Alterations in ventricular K(ATP) channel properties during aging. Aging Cell 2013;12:167-176.
11. Jin K, Minami M, Xie L, et al. Ischemia-induced neurogenesis is preserved but reduced in the aged rodent brain. Aging Cell 2004;3:373-377.
12. Won SJ, Xie L, Kim SH, et al. Influence of age on the response to fibroblast growth factor-2 treatment in a rat model of stroke. Brain Res 2006;1123:237-244.
13. de Luis DA, Soto GD, Conde R, Izaola O, de la Fuente B. Relation of leptin and adiponectin with cardiovascular risk factors, intact parathormone, and vitamin D levels in patients with primary hyperparathyroidism. J Clin Lab Anal 2012;26:398-402.
14. Oliveira CS, Saddi-Rosa P, Crispim F, et al. Association of ADIPOQ variants, total and high molecular weight adiponectin levels with coronary artery disease in diabetic and non-diabetic Brazilian subjects. J Diabetes Complications 2012;26:94-98.
15. Das SK, Patel VB, Oudit GY. Beneficial effects of grape resveratrol on serum adiponectin and inflammation: clinical trial in patients with stable coronary artery disease: editorial to: "Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease" by J. Tome-Carneiro et al. Cardiovasc Drugs Ther 2013;27:1-4.
16. Hashimoto N, Kanda J, Nakamura T, et al. Association of hypoadiponectinemia in men with early onset of coronary heart disease and multiple coronary artery stenoses. Metabolism 2006;55:1653-1657.
17. Efstathiou SP, Tsioulos DI, Tsiakou AG, Gratsias YE, Pefanis AV, Mountokalakis TD. Plasma adiponectin levels and five-year survival after first-ever ischemic stroke. Stroke 2005;36:1915-1919.
18. Arita Y, Kihara S, Ouchi N, et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 2002;105:2893-2898.
19. Okamoto Y, Kihara S, Ouchi N, et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002;106:2767-2770.
20. Ouchi N, Kobayashi H, Kihara S, et al. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 2004;279:1304-1309.
21. Shibata R, Ouchi N, Kihara S, Sato K, Funahashi T, Walsh K. Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling. J Biol Chem 2004;279:28670-28674.
22. Nishimura M, Izumiya Y, Higuchi A, et al. Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms. Circulation 2008;117:216-223.
23. Shen L, Miao J, Yuan F, et al. Overexpression of adiponectin promotes focal angiogenesis in the mouse brain following middle cerebral artery occlusion. Gene Ther 2013;20:93-101.
24. Lu H, Wang Y, Yuan F, Liu J, Zeng L, Yang GY. Overexpression of netrin-1 improves neurological outcomes in mice following transient middle cerebral artery occlusion. Front Med 2011;5:86-93.
25. Su H, Yang GY. Treatment of focal brain ischemia with viral vector-mediated gene transfer. Methods Mol Biol 2011;686:429-446.
26. Chen YC, Wu JS, Yang ST, et al. Stroke, angiogenesis and phytochemicals. Front Biosci (Schol Ed) 2012;4:599-610.
27. Lapchak PA, Araujo DM. Advances in ischemic stroke treatment: neuroprotective and combination therapies. Expert Opin Emerg Drugs 2007;12:97-112.
28. Gursoy-Ozdemir Y, Yemisci M, Dalkara T. Microvascular protection is essential for successful neuroprotection in stroke. J Neurochem 2012;123(Suppl 2):2-11.
29. Terpolilli NA, Kim SW, Thal SC, et al. Inhalation of nitric oxide prevents ischemic brain damage in experimental stroke by selective dilatation of collateral arterioles. Circ Res 2012;110:727-738.
30. Zhu W, Fan Y, Frenzel T, et al. Insulin growth factor-1 gene transfer enhances neurovascular remodeling and improves long-term stroke outcome in mice. Stroke 2008;39:1254-1261.
31. Yang JP, Liu HJ, Liu XF. VEGF promotes angiogenesis and functional recovery in stroke rats. J Invest Surg 2010;23:149-155.
32. Lu H, Wang Y, He X, et al. Netrin-1 hyperexpression in mouse brain promotes angiogenesis and long-term neurological recovery after transient focal ischemia. Stroke 2012;43:838-843.
33. Shen F, Fan Y, Su H, et al. Adeno-associated viral vector-mediated hypoxia-regulated VEGF gene transfer promotes angiogenesis following focal cerebral ischemia in mice. Gene Ther 2008;15:30-39.
34. Zeng XN, Xie LL, Liang R, Sun XL, Fan Y, Hu G. AQP4 knockout aggravates ischemia/reperfusion injury in mice. CNS Neurosci Ther 2012;18:388-394.
35. Li Y, Chopp M, Chen J, et al. Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J Cereb Blood Flow Metab 2000;20:1311-1319.
36. Zhang L, Schallert T, Zhang ZG, et al. A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia. J Neurosci Methods 2002;117:207-214.
37. Ma J, Xiong JY, Hou WW, et al. Protective effect of carnosine on subcortical ischemic vascular dementia in mice. CNS Neurosci Ther 2012;18:745-753.
38. Shen F, Su H, Liu W, Kan YW, Young WL, Yang GY. Recombinant adeno-associated viral vector encoding human VEGF165 induces neomicrovessel formation in the adult mouse brain. Front Biosci 2006;11:3190-3198.
39. Arumugam TV, Phillips TM, Cheng A, Morrell CH, Mattson MP, Wan R. Age and energy intake interact to modify cell stress pathways and stroke outcome. Ann Neurol 2010;67:41-52.
40. Zhang L, Zhang RL, Wang Y, et al. Functional recovery in aged and young rats after embolic stroke: treatment with a phosphodiesterase type 5 inhibitor. Stroke 2005;36:847-852.
41. Heeschen C, Lehmann R, Honold J, et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004;109:1615-1622.
42. Shimada T, Takeshita Y, Murohara T, et al. Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse. Circulation 2004;110:1148-1155.
43. Rivard A, Fabre JE, Silver M, et al. Age-dependent impairment of angiogenesis. Circulation 1999;99:111-120.
44. Yamaura H, Matsuzawa T. Decrease in capillary growth during aging. Exp Gerontol 1980;15:145-150.
45. Deng B, Gou X, Chen H, et al. Targeted delivery of Neurogenin-2 protein in the treatment for cerebral ischemia-reperfusion injury. Biomaterials 2013;34:8786-8797.
46. Doeppner TR, Nagel F, Dietz GP, et al. TAT-Hsp70-mediated neuroprotection and increased survival of neuronal precursor cells after focal cerebral ischemia in mice. J Cereb Blood Flow Metab 2009;29:1187-1196.
47. Chen C, Wang Y, Yang GY. Stem cell-mediated gene delivering for the treatment of cerebral ischemia: progress and prospectives. Curr Drug Targets 2013;14:81-89.
48. Zhu J, Zhou L, XingWu F. Tracking neural stem cells in patients with brain trauma. N Engl J Med 2006;355:2376-2378.
49. Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 2005;57:874-882.
50. Barbosa da Fonseca LM, Gutfilen B, Rosado de Castro PH, et al. Migration and homing of bone-marrow mononuclear cells in chronic ischemic stroke after intra-arterial injection. Exp Neurol 2010;221:122-128.
51. Sun Y, Jin K, Xie L, et al. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 2003;111:1843-1851.
52. Greenberg DA, Jin K. From angiogenesis to neuropathology. Nature 2005;438:954-959.
53. Nagata D, Mogi M, Walsh K. AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. J Biol Chem 2003;278:31000-31006.
54. Ouchi N, Shibata R, Walsh K. AMP-activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle. Circ Res 2005;96:838-846.